trial group:Pembrolizumab and Yiqi Jiedu compound

2 trials

Sponsors

LongHua Hospital, Shanghai University of Traditional Chinese Medicine

Conditions

non-small lung cancer cell, NSCLC

Early Phase 1

The Clinical study of Yiqi Jiedu compound combined with Pembrolizumab in the treatment of non-small cell lung cancer patients with chemotherapy resistance

RecruitingChiCTR2000036977

LongHua Hospital, Shanghai University of Traditional Chinese Medicinenon-small lung cancer cell, NSCLC

Start: 2020-10-01Updated: 2020-09-28

The Clinical study of Yiqi Jiedu compound combined with Pembrolizumab in the treatment of non-small cell lung cancer patients with chemotherapy resistance

RecruitingITMCTR2000003721

LongHua Hospital, Shanghai University of Traditional Chinese Medicinenon-small lung cancer cell, NSCLC

Start: 2020-10-01Updated: 2023-02-20